Abstract
The anti-osteoporosis effect of Ganoderma lucidum (G. lucidum, Lingzhi) is closely associated with inhibition of osteoclastogenesis in the charge of osteoclasts. This article reviewed the anti-osteoporosis effect of Ganoderma and its active components, including a kind of triterpenoids, a polysaccharide and a protein named Ling Zhi-8 (LZ-8). Triterpenoids are a kind of active compounds as candidates for the treatment of osteoporosis. Among these, ganoderic acids are currently considered as the most important and potential components, and their structure-activity relationship highlights the essential group to hamper osteoclast differentiation. The data confirmed that the active compounds isolated from triterpenoids and meroterpenoids could suppress bone resorption of osteoclast via RANKL/RANK pathway and/or its downstream signaling transduction related to ERK, JNK and p38 MAPKs, contributing to inhibition of the level of c-Fos and NFATc1, two key target genes of osteoclast for osteoclastogenesis. However, the comprehensive mechanism remains to be elucidated in the future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ensrud KE, Crandall CJ (2017) Osteoporosis. Ann Intern Med 167(3):ITC17–ITC32
Mani D, Singh D, Gupta A (2018) The underlying pathophysiology and therapeutic approaches for osteoporosis. Med Res Rev 38(6):2024–2057
Briggs AM, Cross MJ, Hoy DG et al (2016) Musculoskeletal health conditions represent a global threat to healthy aging: a report for the 2015 World Health Organization World Report on Ageing and Health. Gerontologist 56(Suppl 2):S243–S255
Tosteson ANA and Vanness DJ (2008) Chapter 3 - The economics of ssteoporosis. In: Marcus R, Feldman D, Nelson DA et al Osteoporosis, Third edn, Two Volume Set, Academic Press, San Diego, pp 37–45
Curry SJ, Krist AH, Owens DK et al (2018) Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA 319(24):2521–2531
Shizhen L (1978) A compendium of Materia Medica. People’s Health Publisher, Beijing
Xinzhuang L (2013) Health tea granule for preventing osteoporosis and its preparation method. China, CN 103211071A
Hidaka S, Okamoto Y, Yamada Y et al (2011) A Japanese herbal medicine, Chujo-to, has a beneficial effect on osteoporosis in rats. Phytother Res 13(1):14–19
Xu M, Dick IM, Day R et al (2003) Effects of a herbal extract on the bone density, strength and markers of bone turnover of mature Ovariectomized rats. Am J Chin Med 31(01):87–101
Miyamoto I, Liu J, Shimizu K et al (2009) Regulation of osteoclastogenesis by ganoderic acid DM isolated from Ganoderma lucidum. Eur J Pharmacol 602(1):1–7
Ahmad MF (2018) Ganoderma lucidum: persuasive biologically active constituents and their health endorsement. Biomed Pharmacother 107:507–519
Elhassaneen YA, Ragab SS, Salman MS (2016) The potential effects of Reishi mushroom (Ganoderma lucidum) consumption on bone health indices and serum minerals profile disorders induced by CCl4 on rats. Pyrex J Med Plant Res 2(1):001–007
Wang X-Y, Bao H-Y, Bau T et al (2016) Healing effect of Ganoderma sinense fruiting body extracts on rat radius fracture. Mycosystema 35(11):1387–1398
Shiao MS (2003) Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem Rec 3(3):172–180
Liu J, Shiono J, Shimizu K et al (2009) Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor. Bioorg Med Chem Lett 19(8):2154–2157
Liu J, Shiono J, Shimizu K et al (2010) Ganoderic acids from Ganoderma lucidum: inhibitory activity of osteoclastic differentiation and structural criteria. Planta Med 76(2):137–139
Tran PT, Dat NT, Dang NH et al (2019) Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1. Phytomedicine 55:1–8
GE F, Ge F (2016) Effect of taishan red Ganoderma lucidum extract on bone mass in rats with osteoporosis. J Shenyang Med Coll 18(1):21–22
Kino K, Yamashita A, Yamaoka K et al (1989) Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium. J Biol Chem 264(1):472
Hsu HA, Wu CY, Chu JS et al (2014) Effect of recombinant human bone morphogenetic protein-2 and Ling Zhi-8 on osteogenesis: a comparative study using a rabbit sinus model. J Oral Maxillofac Surg 72(9):1703 e1–1703 e10
Hsu HY, Kuan YC, Lin TY et al (2013) Reishi protein LZ-8 induces FOXP3(+) Treg expansion via a CD45-dependent signaling pathway and alleviates acute intestinal inflammation in mice. Evid Based Complement Alternat Med 2013:513542
Zhang J, Sun L, Zapata PA et al (2017) Anti-inflammatory bone protective effects of Nano-protein extracts from mushroom species: Ganoderma lucidum and Pleurotus ostreatus. J Nanosci Nanotechnol 17(8):5884–5889
Yu T (2014) Protective effect and mechanism of recombinant Ganoderma lucidum immunoregulatory protein on rats with osteoporosis. Jilin University, Changchun
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yang, Y., Yang, B. (2019). Anti-osteoporosis Effect of Ganoderma (Lingzhi) by Inhibition of Osteoclastogenesis. In: Lin, Z., Yang, B. (eds) Ganoderma and Health. Advances in Experimental Medicine and Biology, vol 1182. Springer, Singapore. https://doi.org/10.1007/978-981-32-9421-9_11
Download citation
DOI: https://doi.org/10.1007/978-981-32-9421-9_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9420-2
Online ISBN: 978-981-32-9421-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)